We thank Mourad and Levy for their constructive Correspondence (Interaction between
RAAS inhibitors and ACE2 in the context of COVID-19. Nat. Rev. Cardiol. https://doi …

Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐
19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection …

Aims Data on the impact of COVID‐19 in chronic heart failure (CHF) patients and its
potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study …

Cardiac injury in patients infected with the novel Coronavirus (COVID-19) seems to be
associated with higher morbimortality. We provide a broad review of the clinical evolution of …

The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly
reached pandemic proportions, and knowledge about this virus and coronavirus disease …

ACE2 is a receptor of entry of SARS-CoV-2 into the host cells, and its upregulation has been
implicated in increasing susceptibility of individuals to this infection. The clinical picture of …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …

Aims The current pandemic coronavirus SARS-CoV-2 infects a wide age group but
predominantly elderly individuals, especially men and those with cardiovascular disease …

Abstract Although coronavirus disease 2019 (COVID-19) predominantly disrupts the
respiratory system, there is accumulating experience that the disease, particularly in its more …